MedTrace Logo

Expanded Access Program for Patients at Risk for Catheter-related Infections Who Are Not Eligible for DefenCath® Clinical Trials

NCT06707480 · Status: AVAILABLE · Type: EXPANDED_ACCESS

Last updated 2026-05-18

No results posted yet for this study

Summary

The EAP for DefenCath is designed to provide access to a broader population of adult and pediatric patients using catheters for various serious medical conditions. A key aspect of this EAP is its focus on individuals who, due to their unique clinical circumstances, are either ineligible for participation in ongoing clinical trials or do not meet the criteria outlined in the current approved FDA label for DefenCath.

Conditions

  • Catheter-related Bloodstream Infection

Interventions

DRUG

Taurolidine and Heparin

Catheter Lock Solution

Sponsors & Collaborators

  • CorMedix

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06707480 on ClinicalTrials.gov